Ajovy is a prescription drug that is used to prevent migraine headaches. It was approved by the U.S. Food and Drug Administration (FDA) in 2018 and is now widely used by people suffering from chronic migraine. While Ajovy has proven to be an effective treatment for some patients, it is important to understand the potential side effects associated with the drug in order to ensure its safe and effective use. This article will explore the potential side effects of Ajovy and how they can be managed.
Ajovy is a medication that is used to prevent migraine headaches. It is a monoclonal antibody that binds to calcitonin gene-related peptide (CGRP) receptors on the surface of nerve cells in the brain. By blocking the action of CGRP, Ajovy is able to reduce the frequency and intensity of migraine headaches. Ajovy is administered as an injection once every four weeks and is available in both an auto-injector and a prefilled syringe.
Like all medications, Ajovy can cause side effects. The most common side effects of Ajovy are injection site reactions, such as redness, itching, pain, swelling, and irritation. Other common side effects include nausea, fatigue, and upper respiratory tract infections. In rare cases, Ajovy can cause serious side effects. These include anaphylaxis, a severe allergic reaction that can cause difficulty breathing, hives, and swelling of the face, lips, tongue, and throat. It is important to seek medical attention immediately if any of these symptoms occur. Ajovy can also cause liver damage, which can lead to jaundice, dark urine, and abdominal pain. It is important to speak to a doctor if any of these symptoms occur. Additionally, Ajovy can cause an increase in blood pressure, which can lead to dizziness, headaches, and blurred vision.
The side effects of Ajovy can be managed with proper monitoring and treatment. It is important to speak to a doctor if any side effects occur, as they may be able to adjust the dosage or switch to a different medication. Additionally, it is important to monitor for any changes in blood pressure, as this can be an indication of an increase in blood pressure. It is also important to stay hydrated and get plenty of rest. Additionally, it is important to avoid alcohol and other substances that can increase the risk of side effects.
Ajovy is an effective medication for preventing migraine headaches, but it is important to understand the potential side effects associated with the drug. Common side effects include injection site reactions, nausea, fatigue, and upper respiratory tract infections. In rare cases, Ajovy can cause serious side effects, such as anaphylaxis, liver damage, and increased blood pressure. It is important to speak to a doctor if any side effects occur, as they may be able to adjust the dosage or switch to a different medication. Additionally, it is important to stay hydrated and get plenty of rest, as well as avoid alcohol and other substances that can increase the risk of side effects.
1.
Study finds 81% of cancer cures touted by TikTok videos are fake
2.
Telemedicine Not Reaching Rural Psychiatric Patients
3.
Parents, teachers at Missouri school want answers after string of cancer diagnoses
4.
A study outlines the need for policies that enhance cancer patients' autonomy and information.
5.
'It's rare and it's scary.' Dark spot on your fingernail could mean cancer
1.
The Importance of Understanding Your D-Dimer Levels: A Comprehensive Guide
2.
Inside Oncology Trials: From Protocol to Progress in Cancer Research and Care
3.
Understanding Mantle Cell Lymphoma Prognosis.
4.
Predicting Incidental Prostate Cancer in BPH Surgery Patients
5.
Navigating the Challenges of Vaso-Occlusive Crisis: A Guide for Patients and Caregivers
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
ESMO Breast Cancer 2022: P Reality X- A Restrospective Analysis
2.
Cost Burden/ Burden of Hospitalization For R/R ALL Patients
3.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
4.
Updates on Standard V/S High Risk Myeloma Treatment
5.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation